|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.67 USD | +2.00% |
|
-1.21% | +5.97% |
| Jan. 20 | RBC Raises Price Target on Incyte to $95 From $92, Keeps Sector Perform Rating | MT |
| Jan. 20 | Wells Fargo Downgrades Incyte to Equalweight From Overweight, Adjusts PT to $107 From $116 | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 4.24B | 0.77% | 9.76% | 5.27% | 3.72% | -4.29x | |
| 14.2B | 31.07% | 36.7% | 19.23% | 15.02% | -1.11x | |
| 3.08B | 23.82% | 29.03% | 10.45% | 6.49% | 0.1x | |
| 15.56B | 19.3% | 28.72% | 16.36% | 7.75% | 1.74x | |
| 6.37B | 17.31% | 13.59% | 11.21% | 6.48% | 0.99x | |
| 9.68B | 16.87% | 31.16% | 10.36% | 5.95% | 1.06x | |
| 1.29B | -1% | -8.02% | -0.74% | -0.45% | -11.4x | |
| 69.63M | 59.01% | 24.7% | 28.77% | 18.72% | -6.16x | |
| 3.24B | -110.04% | -121.91% | -28.77% | -21.87% | 1.87x | |
| 222M | -241.44% | -267.22% | 35.11% | -73.11% | -1.77x | |
| 681M | -10.97% | -17.14% | -8.58% | -7.13% | 8.63x | |
| 2.35B | 14.93% | 22.42% | 10.9% | 5.41% | 1.59x | |
| 10.9M | -2,957.71% | -3,477.43% | -33.47% | - | 3.99x | |
| 2.85B | 14.96% | 16.97% | 8.05% | 6.17% | -0.93x | |
| 386M | -74.47% | -72.74% | -231.63% | -49.66% | 0.49x | |
| 308M | 4.73% | 4.18% | 0.85% | - | -5.29x | |
| 1.25B | 22.95% | 28.06% | 14.19% | 8.74% | 0.28x | |
| 291M | 30.69% | 22.61% | 10.34% | - | -8.45x | |
| 7.47B | 2.18% | 18.81% | 2.79% | 0.74% | 5.16x | |
| Average | 3.87B | -165.11% | -193.57% | -6.28% | -4.19% | -0.71x | |
| Weighted average by Cap. | 6.85B | -68.76% | -80.14% | 4.74% | 2.2% | -0.36x |
- Stock Market
- Equities
- INCY Stock
- Sector Incyte Corporation
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
